RAPT — RAPT THERAPEUTICS INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in RAPT THERAPEUTICS INC (RAPT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.88% (2025 Q3)
Avg. % of fund
0.56%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 34,449 +8,415 +32.3% 0.88% $888K $25.79
2025 Q2 INITIATED 26,034 — — 0.25% $208K $8.00
% of Fund (quarterly)    RAPT price (monthly, adj. close)

Other funds also holding RAPT

As of 2025 Q4 — sorted by position size

Medicxi Ventures Management (Jersey) Ltd 3Y 11.33% FCPM III SERVICES B.V. 8.14% Column Group LLC 3Y 6.39% GREAT POINT PARTNERS LLC 3Y 7Y 6.38% BOONE CAPITAL MANAGEMENT LLC 3Y 5.0% TCG Crossover Management, LLC 3Y 2.89% Octagon Capital Advisors LP 3Y 2.36% Redmile Group, LLC 3Y 7Y 2.21% Velan Capital Investment Management LP 3Y 2.12% Caligan Partners LP 3Y 1.8%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings